{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:57:22Z","timestamp":1793717842330,"version":"4.6.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shenzhen High-level Hospital Construction Fund","award":["G2022153"],"award-info":[{"award-number":["G2022153"]}]},{"name":"Shenzhen Fund for Guangdong Provincial High-level Clinical Key Spcialties","award":["SZGSP011"],"award-info":[{"award-number":["SZGSP011"]}]},{"name":"Science and Technology Innovation Committee of Shenzhen Municipality","award":["JCYJ20220531102202005"],"award-info":[{"award-number":["JCYJ20220531102202005"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2024A1515012118"],"award-info":[{"award-number":["2024A1515012118"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-21744-1","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:13:43Z","timestamp":1738739623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The triglyceride-glucose index trajectories are associated with cardiovascular diseases in people living with HIV: evidence from a prospective cohort study in China, 2005\u20132022"],"prefix":"10.1186","volume":"25","author":[{"given":"Yinsong","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"21744_CR1","unstructured":"Global AIDS update 2023. Joint United Nations Programme on HIV\/AIDS; 2023. Available at: https:\/\/www.unaids.org\/en\/resources\/documents\/2023\/global-aids-update-2023. Accessed 3 June 2024."},{"issue":"1","key":"21744_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00098-22","volume":"37","author":"I Nazari","year":"2024","unstructured":"Nazari I, Feinstein MJ. Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management. Clin Microbiol Rev. 2024;37(1): e0009822.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"21744_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jmii.2019.03.006","volume":"52","author":"PY Wu","year":"2019","unstructured":"Wu PY, Chen MY, Sheng WH, Hsieh SM, Chuang YC, Cheng A, et al. Estimated risk of cardiovascular disease among the HIV-positive patients aged 40 years or older in Taiwan. J Microbiol Immunol Infect. 2019;52(4):549\u201355.","journal-title":"J Microbiol Immunol Infect"},{"issue":"7","key":"21744_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","volume":"15","author":"M Smit","year":"2015","unstructured":"Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"21744_CR5","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/S2352-3018(18)30295-9","volume":"6","author":"KN Althoff","year":"2019","unstructured":"Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C, et al. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. Lancet HIV. 2019;6(2):e93-104.","journal-title":"Lancet HIV"},{"issue":"2","key":"21744_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/135965350801300215","volume":"13","author":"AN Phillips","year":"2008","unstructured":"Phillips AN, Carr A, Neuhaus J, Visnegarwala F, Prineas R, Burman WJ, et al. Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir Ther. 2008;13(2):177\u201387.","journal-title":"Antivir Ther"},{"issue":"7","key":"21744_CR7","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2352-3018(22)00094-7","volume":"9","author":"B Neesgaard","year":"2022","unstructured":"Neesgaard B, Greenberg L, Mir\u00f3 JM, et al. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium. Lancet HIV. 2022;9(7):e474\u201385.","journal-title":"Lancet HIV"},{"issue":"5","key":"21744_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jacc.2018.04.083","volume":"72","author":"RM Alvi","year":"2018","unstructured":"Alvi RM, Neilan AM, Tariq N, et al. Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure. J Am Coll Cardiol. 2018;72(5):518\u201330.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"21744_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/2047487315579291","volume":"23","author":"N Friis-M\u00f8ller","year":"2016","unstructured":"Friis-M\u00f8ller N, Ryom L, Smith C, Weber R, Reiss P, Dabis F, et al. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study. Eur J Prev Cardiol. 2016;23(2):214\u201323.","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"21744_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11904-021-00567-w","volume":"18","author":"AC Achhra","year":"2021","unstructured":"Achhra AC, Lyass A, Borowsky L, Bogorodskaya M, Plutzky J, Massaro JM, et al. Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations. Curr HIV\/AIDS Rep. 2021;18(4):271\u20139.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"21744_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamacardio.2022.4873","volume":"8","author":"C Soares","year":"2023","unstructured":"Soares C, Kwok M, Boucher KA, Haji M, Echouffo-Tcheugui JB, Longenecker CT, et al. Performance of Cardiovascular Risk Prediction Models Among People Living With HIV: A Systematic Review and Meta-analysis. JAMA Cardiol. 2023;8(2):139\u201349.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"21744_CR12","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1186\/s12889-020-09896-8","volume":"20","author":"AR Webel","year":"2020","unstructured":"Webel AR, Schexnayder J, Rentrope CR, Bosworth HB, Hileman CO, Okeke NL, Vedanthan R, Longenecker CT. The influence of healthcare financing on cardiovascular disease prevention in people living with HIV. BMC Public Health. 2020;20(1):1768.","journal-title":"BMC Public Health"},{"issue":"4","key":"21744_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"21744_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"21744_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","volume":"32","author":"DH Son","year":"2022","unstructured":"Son DH, Lee HS, Lee YJ, Lee JH, Han JH. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2022;32(3):596\u2013604.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"21744_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.585776","volume":"8","author":"W Guo","year":"2021","unstructured":"Guo W, Zhu W, Wu J, Li X, Lu J, Qin P, et al. Triglyceride glucose index is associated with arterial stiffness and 10-year cardiovascular disease risk in a chinese population. Front Cardiovasc Med. 2021;8: 585776.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"21744_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12933-023-02060-7","volume":"22","author":"S Tao","year":"2023","unstructured":"Tao S, Yu L, Li J, Xie Z, Huang L, Yang D, et al. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023;22(1):322.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"21744_CR18","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1038\/s41598-019-43776-5","volume":"9","author":"S Li","year":"2019","unstructured":"Li S, Guo B, Chen H, Shi Z, Li Y, Tian Q, et al. The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis. Sci Rep. 2019;9(1):7320.","journal-title":"Sci Rep"},{"key":"21744_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338.","journal-title":"Annu Rev Clin Psychol"},{"issue":"11","key":"21744_CR20","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1007\/s00134-022-06890-z","volume":"48","author":"SV Bhavani","year":"2022","unstructured":"Bhavani SV, Semler M, Qian ET, Verhoef PA, Robichaux C, Churpek MM, et al. Development and validation of novel sepsis subphenotypes using trajectories of vital signs. Intensive Care Med. 2022;48(11):1582\u201392.","journal-title":"Intensive Care Med"},{"issue":"1","key":"21744_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"21744_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-020-01121-5","volume":"19","author":"N Barzegar","year":"2020","unstructured":"Barzegar N, Tohidi M, Hasheminia M, Azizi F, Hadaegh F. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study. Cardiovasc Diabetol. 2020;19(1):155.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"21744_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12933-020-01186-2","volume":"19","author":"B Park","year":"2020","unstructured":"Park B, Lee YJ, Lee HS, Jung DH. The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data. Cardiovasc Diabetol. 2020;19(1):210.","journal-title":"Cardiovasc Diabetol"},{"issue":"13","key":"21744_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.858209","volume":"24","author":"S Tai","year":"2022","unstructured":"Tai S, Fu L, Zhang N, Zhou Y, Xing Z, Wang Y. Impact of Baseline and Trajectory of Triglyceride-Glucose Index on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne). 2022;24(13): 858209.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"21744_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-022-01453-4","volume":"21","author":"Y Yan","year":"2022","unstructured":"Yan Y, Wang D, Sun Y, Ma Q, Wang K, Liao Y, et al. Triglyceride-glucose index trajectory and arterial stiffness: results from Hanzhong adolescent hypertension cohort study. Cardiovasc Diabetol. 2022;21(1):33.","journal-title":"Cardiovasc Diabetol"},{"key":"21744_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.628109","volume":"7","author":"XC Liu","year":"2020","unstructured":"Liu XC, He GD, Lo K, et al. The triglyceride-glucose index, an insulin resistance marker, was non-linear associated with all-cause and cardiovascular mortality in the general population. Front Cardiovasc Med. 2020;7: 628109.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"21744_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-024-02152-y","volume":"23","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhang Y, Chen S, Xiang H, Ouyang J, Liu H, et al. Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study. Cardiovasc Diabetol. 2024;23(1):80.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"21744_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-021-01305-7","volume":"20","author":"A Wang","year":"2021","unstructured":"Wang A, Tian X, Zuo Y, et al. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):113.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"21744_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-022-01548-y","volume":"21","author":"J Zhao","year":"2022","unstructured":"Zhao J, Fan H, Wang T, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123.","journal-title":"Cardiovasc Diabetol"},{"key":"21744_CR30","doi-asserted-by":"publisher","first-page":"1483468","DOI":"10.3389\/fendo.2024.1483468","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Li H, Chen X, Liang X. Association between various insulin resistance indices and cardiovascular disease in middle-aged and elderly individuals: evidence from two prospectives nationwide cohort surveys. Front Endocrinol (Lausanne). 2024;15:1483468.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"21744_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-024-02152-y","volume":"23","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhang Y, Chen S, et al. Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study. Cardiovasc Diabetol. 2024;23(1):80.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"21744_CR32","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed G, Aoun L, Bou Zerdan M, et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022;23(2):786.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"21744_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","volume":"22","author":"B Che","year":"2023","unstructured":"Che B, Zhong C, Zhang R, Pu L, Zhao T, Zhang Y, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"21744_CR34","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S2352-3018(20)30036-9","volume":"7","author":"K So-Armah","year":"2020","unstructured":"So-Armah K, Benjamin LA, Bloomfield GS, Feinstein MJ, Hsue P, Njuguna B, et al. HIV and cardiovascular disease. Lancet HIV. 2020;7(4):e279\u201393.","journal-title":"Lancet HIV"},{"issue":"12","key":"21744_CR35","doi-asserted-by":"publisher","first-page":"e860","DOI":"10.1016\/S2352-3018(19)30263-2","volume":"6","author":"H Lin","year":"2019","unstructured":"Lin H, Ding Y, Ning C, Qiao X, Chen X, Chen X, et al. Age-specific associations between HIV infection and carotid artery intima-media thickness in China: a cross-sectional evaluation of baseline data from the CHART cohort. Lancet HIV. 2019;6(12):e860\u20138.","journal-title":"Lancet HIV"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21744-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-21744-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21744-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:13:57Z","timestamp":1738739637000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-21744-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21744"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-21744-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5352658\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was compliant with the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Institutional Review Board of Shenzhen Third People\u2019s Hospital (No. 2022\u2013143). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"465"}}